Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Instituto Nacional de Cancerologia E.S.E (Site 0807)

Bogota, Cundinamarca 111161, ColombiaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Closed trials

Completed
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
NCT03142334· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Instituto Nacional de Cancerologia E.S.E (Site 0807): trial site – Frontlight Research